Patients at high risk for cardiovascular disease are less likely to lose days to death when treated with icosapent ethyl than with placebo.
Medscape News Canada
Source link : https://www.medscape.com/viewarticle/ipe-may-cut-days-lost-hospitalization-or-death-cvd-2025a1000tb8?src=rss
Author :
Publish date : 2025-10-28 12:50:00
Copyright for syndicated content belongs to the linked Source.
